DIN 02535939 — MINT-ENTACAPONE 200 MG
MINT-ENTACAPONE is a tablet of Entacapone marketed by MINT PHARMACEUTICALS INC. The full Entacapone monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.
- DIN
- 02535939
- Brand name
- MINT-ENTACAPONE
- Active ingredient
- Entacapone
- Strength
- 200 MG
- Dosage form
- TABLET
- Route
- ORAL
- Manufacturer
- MINT PHARMACEUTICALS INC
- Health Canada status
- MARKETED
- Drug class
- Catechol-O-methyltransferase (COMT) inhibitor - antiparkinsonian agent
Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.
Other Entacapone products
| DIN | Brand | Strength | Form | Manufacturer | Status |
|---|---|---|---|---|---|
| 02243763 | COMTAN | 200 MG | TABLET | SANDOZ CANADA INCORPORATED | DORMANT |
| 02380005 | SANDOZ ENTACAPONE | 200 MG | TABLET | SANDOZ CANADA INCORPORATED | MARKETED |
| 02375559 | TEVA-ENTACAPONE | 200 MG | TABLET | TEVA CANADA LIMITED | MARKETED |